ID

29740

Beschrijving

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562); ODM derived from: https://clinicaltrials.gov/show/NCT00705224

Link

https://clinicaltrials.gov/show/NCT00705224

Trefwoorden

  1. 17-04-18 17-04-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

17 april 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hepatitis C, Chronic NCT00705224

Eligibility Hepatitis C, Chronic NCT00705224

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed diagnosis of chc according to local regulations
Beschrijving

Hepatitis C, Chronic

Datatype

boolean

Alias
UMLS CUI [1]
C0524910
naïve pegylated interferon (peg-ifn) chc patient
Beschrijving

Peginterferon naive Chronic Hepatitis C

Datatype

boolean

Alias
UMLS CUI [1,1]
C0982327
UMLS CUI [1,2]
C0919936
UMLS CUI [1,3]
C0524910
no contraindications for peg-ifn chc therapy
Beschrijving

Absence Medical contraindication Peginterferon Chronic Hepatitis C

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C0982327
UMLS CUI [1,4]
C0524910
negative urine pregnancy test result (for females of childbearing potential) documented within the 24-hour period prior to the first dose of study drugs. additionally, all female patients of childbearing potential and all males with female partners of childbearing potential must use two forms of effective contraception (combined) during treatment and 6 months after treatment end
Beschrijving

Childbearing Potential Urine pregnancy test negative | Childbearing Potential Contraceptive methods Quantity | Gender Partner Childbearing Potential Contraceptive methods Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430057
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0682323
UMLS CUI [3,3]
C3831118
UMLS CUI [3,4]
C0700589
UMLS CUI [3,5]
C1265611
willingness to give written informed consent and willingness to participate in and comply with the study requirements.
Beschrijving

Informed Consent | Protocol Compliance

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
peg-ifn treatment in history
Beschrijving

Peginterferon History

Datatype

boolean

Alias
UMLS CUI [1,1]
C0982327
UMLS CUI [1,2]
C0019665
contraindications for peg-ifn chc therapy
Beschrijving

Medical contraindication Peginterferon Chronic Hepatitis C

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0982327
UMLS CUI [1,3]
C0524910
females who are pregnant or breast-feeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
male partners of females who are pregnant
Beschrijving

Gender Partner Pregnancy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0682323
UMLS CUI [1,3]
C0032961
potentially unreliable participants, and those judged by the investigator to be unsuitable for the study.
Beschrijving

Study Subject Unreliable | Study Subject Participation Status Inappropriate

Datatype

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C4061925
UMLS CUI [2,1]
C2348568
UMLS CUI [2,2]
C1548788

Similar models

Eligibility Hepatitis C, Chronic NCT00705224

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C, Chronic
Item
confirmed diagnosis of chc according to local regulations
boolean
C0524910 (UMLS CUI [1])
Peginterferon naive Chronic Hepatitis C
Item
naïve pegylated interferon (peg-ifn) chc patient
boolean
C0982327 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
Absence Medical contraindication Peginterferon Chronic Hepatitis C
Item
no contraindications for peg-ifn chc therapy
boolean
C0332197 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C0982327 (UMLS CUI [1,3])
C0524910 (UMLS CUI [1,4])
Childbearing Potential Urine pregnancy test negative | Childbearing Potential Contraceptive methods Quantity | Gender Partner Childbearing Potential Contraceptive methods Quantity
Item
negative urine pregnancy test result (for females of childbearing potential) documented within the 24-hour period prior to the first dose of study drugs. additionally, all female patients of childbearing potential and all males with female partners of childbearing potential must use two forms of effective contraception (combined) during treatment and 6 months after treatment end
boolean
C3831118 (UMLS CUI [1,1])
C0430057 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C3831118 (UMLS CUI [3,3])
C0700589 (UMLS CUI [3,4])
C1265611 (UMLS CUI [3,5])
Informed Consent | Protocol Compliance
Item
willingness to give written informed consent and willingness to participate in and comply with the study requirements.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Peginterferon History
Item
peg-ifn treatment in history
boolean
C0982327 (UMLS CUI [1,1])
C0019665 (UMLS CUI [1,2])
Medical contraindication Peginterferon Chronic Hepatitis C
Item
contraindications for peg-ifn chc therapy
boolean
C1301624 (UMLS CUI [1,1])
C0982327 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
females who are pregnant or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Gender Partner Pregnancy
Item
male partners of females who are pregnant
boolean
C0079399 (UMLS CUI [1,1])
C0682323 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
Study Subject Unreliable | Study Subject Participation Status Inappropriate
Item
potentially unreliable participants, and those judged by the investigator to be unsuitable for the study.
boolean
C0681850 (UMLS CUI [1,1])
C4061925 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial